Pharma Mar S.A. Cash Flow-to-Debt Ratio
Pharma Mar S.A. cash flow-to-debt ratio. Pharma Mar S.A. (PHM) has a Cash Flow-to-Debt Ratio of 0.23x as of December 2025, meaning its operating cash flow of €33.58 Million could theoretically repay 0% of its total liabilities (€143.25 Million) in one year. Check PHM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pharma Mar S.A. (2002–2025)
Cash flow-to-debt ratio of Pharma Mar S.A. from 2002 to 2025. Historical debt coverage capacity for Pharma Mar S.A. across 23 annual periods. Check Pharma Mar S.A. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Pharma Mar S.A. Cash Flow-to-Debt Ratio by Year (2002–2025)
Pharma Mar S.A. cash flow-to-debt ratio by year from 2002 to 2025. Year-by-year debt coverage analysis for Pharma Mar S.A.. For the full cash flow conversion analysis, see Pharma Mar S.A. cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | €53.13 Million | €143.25 Million | ▲ +769.5% |
| 2024 | 0.04x | €6.03 Million | €141.28 Million | ▲ +146.7% |
| 2023 | -0.09x | €-13.45 Million | €147.08 Million | ▼ -140.6% |
| 2022 | 0.23x | €38.32 Million | €170.30 Million | ▲ +66.9% |
| 2021 | 0.13x | €25.68 Million | €190.47 Million | ▼ -89.0% |
| 2020 | 1.23x | €278.94 Million | €227.54 Million | ▲ +649.9% |
| 2019 | -0.22x | €-26.14 Million | €117.25 Million | ▼ -91.3% |
| 2018 | -0.12x | €-16.34 Million | €140.20 Million | ▼ -1215.9% |
| 2017 | -0.01x | €-1.46 Million | €164.74 Million | ▲ +81.8% |
| 2016 | -0.05x | €-8.41 Million | €172.64 Million | ▼ -161.0% |
| 2015 | 0.08x | €11.10 Million | €138.90 Million | ▼ -48.9% |
| 2014 | 0.16x | €22.11 Million | €141.32 Million | ▲ +33.9% |
| 2013 | 0.12x | €16.34 Million | €139.94 Million | ▲ +197.8% |
| 2012 | 0.04x | €6.32 Million | €161.10 Million | ▲ +267.9% |
| 2011 | -0.02x | €-4.28 Million | €183.31 Million | ▲ +79.1% |
| 2010 | -0.11x | €-21.90 Million | €195.96 Million | ▲ +16.1% |
| 2009 | -0.13x | €-22.67 Million | €170.18 Million | ▲ +40.9% |
| 2008 | -0.23x | €-35.66 Million | €158.20 Million | ▲ +38.8% |
| 2007 | -0.37x | €-49.16 Million | €133.51 Million | ▲ +23.1% |
| 2006 | -0.48x | €-56.11 Million | €117.23 Million | ▲ +51.2% |
| 2005 | -0.98x | €-33.03 Million | €33.68 Million | ▼ -98.9% |
| 2003 | -0.49x | €-67.18 Million | €136.20 Million | ▼ -44.6% |
| 2002 | -0.34x | €-35.64 Million | €104.53 Million | — |